We previously showed that LM11A-31 decreased microglial activation in multiple HD mouse models and altered the functional phenotypes of microglia by reducing the concentrations of several cytokines that were elevated in the R6/2 striatum, including interleukin (IL)-6 and tumor necrosis factor (TNF)-α [8, 16]. This evidence concerns the gene TNF and Huntington disease.